HDAC9 and Alzheimer disease: Similarly, both general and class I-selective HDAC inhibitors have been shown to ameliorate cognitive defects in transgenic AD mouse harboring hereditary AD mutation (Kilgore et al., 2010; Ricobaraza et al., 2011).